20,000+ Scientists & Academics
4,000+ Scientific disciplines
20,000+ Projects posted
Trusted by 3,200+ businesses
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss the project scope and fee and hire the expert who best meets your requirements
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but release the funds only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Contact
★★★★★
☆☆☆☆☆
Hire Dr. Kamalika Moulick
United States
Profile Summary
Subject Matter Expertise
Services
Work Experience

Clinical Variant Scientist

Counsyl Inc

August 2016 - Present

Post Doctoral Researcher

Memorial Sloan-Kettering Cancer Center

August 2010 - May 2013

Doctoral Research Fellow

Memorial Sloan-Kettering Cancer Center

May 2005 - July 2010

Teaching Assistant

University of North Carolina at Greensboro

August 2002 - June 2004

Instructor

MCKV Institute of Engineering

August 2001 - June 2002

Education

PhD, Applied Biomedical Sciences (Chemical Biology)

Joan and Sanford I Weill Medical College of Cornell University

July 2004 - July 2010

MS (Chemistry and Biochemistry)

University of North Carolina at Greensboro

August 2002 - June 2004

Post Graduate Diploma in Computer Applications (RCC)

Jadavpur University

August 1999 - August 2000

Certifications
  • Certification details not provided.
Publications
JOURNAL ARTICLE
(2012). Biochemical evidence towards the existence of an oncogenic Hsp90 complex. Cancer Research.
(2011). Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nature Chemical Biology.
(2011). Design, synthesis, and evaluation of small molecule Hsp90 probes. Bioorg. Med. Chem.
(2010). Design of a Flexible Cell-Based Assay for the Evaluation of Heat Shock Protein 70 Expression Modulators. Assay Drug Dev. Technol.
(2009). Heat shock protein inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models. Proc Natl Acad Sci U S A.
(2007). Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proc Natl Acad Sci U S A.
(2007). Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer. Nature Chemical Biology.
(2007). Effects of herbal products and their constituents on human cytochrome P450(2E1) activity. Food Chem. Toxicol.
(2007). High-throughput screening fluorescence polarization assay for tumor-specific hsp90. Biomol. Screen.
(2006). Synthesis of a red-shifted fluorescence polarization probe for Hsp90. Bioorg. Med. Chem. Lett.
(2006). Emerging Hsp90 inhibitors: from discovery to clinic. Anticancer Agents Med. Chem.
CONFERENCE POSTER
(2009). Probing cancer-specific activating signaling pathways through a tumor-specific Hsp90 inhibitor. American Association of Cancer Research (AACR), Annual Meeting.
(2008). Cell-based assay for rapid identification of Hsp70 Modulators. World Pharmaceutical Congress.
(2007). High-throughput screening fluorescence polarization assay for tumor-specific Hsp90. American Association of Cancer Research (AACR), Annual Meeting.
(2006). Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90. American Association of Cancer Research (AACR), Annual Meeting.
(2004). Inhibition of Human Cytochrome P4502e1 by Herbal Extracts and Their Major Isolated Constituents. Southeast Regional Meeting, American Chemical Society (ACS).
(2003). Effects of Echinacea on human metabolizing systems. American Chemical Society (ACS).
CONFERENCE PAPER
(2007). Targeting basal-like breast cancer via purine-scaffold Hsp90 inhibitors. American Association of Cancer Research (AACR), Annual Meeting.
DISSERTATION THESIS
(2006). Interactions of Echinacea and Spilanthes with Human Metabolizing Systems . University of North Carolina at Greensboro.